BioSpace News Archive

OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunology

OSE Immunotherapeutics SA announced the publication of novel data in the peer-reviewed Journal of Immunology on a first-in-class research program with CLEC-1, its novel myeloid immune checkpoint target for cancer immunotherapy.

April 2, 2024
·
7 min read
Business

Crossject advances in its U.S. Strategy and reports Financial Results for 2023

Crossject announces progress on multiple fronts in its clinical development, registration and U.S. commercial strategy and reports its financial results for the year ending December 31, 2023.

April 2, 2024
·
13 min read
Sobi publishes Annual and sustainability report for 2023

Swedish Orphan Biovitrum AB published its Annual and sustainability report for 2023. Inspired by caring and powered by science, the integrated report summarises business and strategy, financial performance, and work on sustainability.

April 2, 2024
·
1 min read
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection

Evaxion Biotech A/S is pleased to announce the successful conclusion of a series of large non-rodent animal infection studies, testing antigens from Evaxion’s preclinical EVX-B1 vaccine candidate against Staphylococcus aureus.

April 2, 2024
·
5 min read
Business

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

EyePoint Pharmaceuticals, Inc. announced the appointment of leading global ophthalmologists to its Scientific Advisory Board, co-chaired by Carl Regillo M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Charles Wykoff, M.D., Ph.D., Director of Research of Retina Consultants of Texas.

April 2, 2024
·
9 min read
Genetown

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

Generation Bio Co. announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024 at 12:45 p.m. ET.

April 2, 2024
·
1 min read
Lone Star Bio

Bio-Path Holdings Provides 2024 Clinical and Operational UpdateClinical Advances Across Multiple Programs with Several Milestones

Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, provides a clinical development and operational update for 2024.

April 2, 2024
·
9 min read
Drug Development

Priovant Therapeutics Announces Positive Phase 2 NEPTUNE Study Results for Brepocitinib in Non-Infectious Uveitis (NIU), Showing Strongest Efficacy Data in NIU Observed to Date

Priovant Therapeutics announced positive results from the Phase 2 study evaluating brepocitinib in non-anterior non-infectious uveitis.

April 2, 2024
·
7 min read
Deals

Ginkgo Bioworks Acquires Modulus Therapeutics’ Cell Therapy Assets to Strengthen Next-Gen CAR Designs

Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, announced the acquisition of Modulus Therapeutics’ cell therapy platform assets, including their chimeric antigen receptor and switch receptor libraries.

April 2, 2024
·
7 min read
Biotech Bay

Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities

Biotricity Inc., a leading Technology-as-a-Service company revolutionizing the medical diagnostic and consumer healthcare field, continues its strategic expansion with the announcement of its latest partnership in neurology to conduct cardiac screenings in patients suffering from neurological issues.

April 2, 2024
·
5 min read